Cotrimoxazole prophylaxis is cost-effective for people starting ART in sub-Saharan Africa
New vaccine against pneumococcal disease approved for UK
Free cotrimoxazole improves retention in care among adults not yet eligible for ART
HPTN 052: early treatment reduces serious illness by 40%